In the Boardroom
Refine Search
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Biotechnology
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including seed financing and Series A. 7 October 2024
Biotechnology
Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies as chief scientific officer. 7 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
article
Austrian biotech company Nabriva Therapeutics has appointed Colin Broom as chief executive. 3 September 2014
article
EMD Serono, a subsidiary of Germany's Merck KGaA, has appointed Drew Young as senior vice president of neurology and immunology, where he will lead the strategic direction of the US neurology and immunology franchise. 2 September 2014
Pharmaceutical
Belgian cell therapy company TiGenix has appointed Marie Paule Richard as chief medical officer, and Mary Carmen Diez as its vice president of medical affairs and new product commercialization. 1 September 2014
Pharmaceutical
French drug major Sanofi has replaced its North American chief Anne Whitaker with Jez Moulding, who will be head of the region’s pharma business following a senior management role in Japan and Asia Pacific. 28 August 2014
Pharmaceutical
French drugmaker Ipsen has appointed Cynthia Schwalm as president and chief executive of its North American operations. 21 August 2014
Pharmaceutical
Allergy specialist Allergan has appointed Jim Hindman as chief financial officer, effective immediately, replacing Jeff Edwards. 19 August 2014
Pharmaceutical
Switzerland-based Basilea Pharmaceutica has appointed David Veitch as its chief commercial officer. 19 August 2014
Biotechnology
British gene and cell therapy company Oxford BioMedica has appointed Paul Blake as chief development officer. 15 August 2014
Pharmaceutical
Coming from her position as president of Sanofi’s North American pharma division, Anne Whitaker has been named chief executive of Synta Pharmaceuticals. 12 August 2014
Pharmaceutical
Astellas Pharma EMEA, the regional headquarters of Japanese drug major Astellas Pharma, has appointed Simon Dew as chief strategy officer. 7 August 2014
Pharmaceutical
Biopharmaceutical company Receptos has appointed Mary Szela and Richard Heyman to the board of directors. 29 July 2014
Pharmaceutical
Quebec-based cardiovascular drug development specialist Milestone Pharmaceuticals has announced the appointment of Francis Plat as chief medical officer. He is a cardiologist with extensive experience in cardio drug development. 21 July 2014
Biotechnology
US-based Neurotrope, developers of diagnostic and therapeutic technologies for the treatment of neurodegenerative diseases, has announced the appointment of co-chairmen Charles Ramat and Paul Freiman as co-chief executives on an interim basis. 21 July 2014
Pharmaceutical
US-based drug development and discovery company Aptuit has appointed Paul Overton as executive vice president, business development and marketing. He is now responsible for all of Aptuit’s sales and marketing activities. 16 July 2014
Pharmaceutical
Bayer Corporation, a US subsidiary of German drug major Bayer has hired Malini Moorthy as head of its litigation department from July 30. 16 July 2014
Pharmaceutical
US-based clinical-stage biopharma company Xencor has announced the appointment of Kurt Gustafson to its board of directors. He will also serve as chair of the audit and compensation committees for the company which develops engineer monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer. 15 July 2014
Pharmaceutical
US-based biopharma Anthera Pharmaceuticals has appointed Chuck Olson as president of its subsidiary Alkira Therapeutics. 15 July 2014
Pharmaceutical
Merck Serono, the biotech unit of Germany’s Merck KGaA, has announced the appointment of Luciano Rossetti as executive vice president and global head of research and development. 14 July 2014
Pharmaceutical
Taiwan-based pharmaceutical company ScinoPharm (TWSE: 1789) says that its president and chief executive will retire at the end of July after 17 years of service. He will be succeeded by Dr Yung-Fa (Fred) Chen, who is currently the company’s vice president of research and development, and chief technology officer, from August 1. 11 July 2014
Pharmaceutical
US-based oncology specialist Jounce Therapeutics has announced the appointment of Richard Murray to chief executive officer. Dr Murray has more than 20 years of experience in building research and development capabilities in small startups and large pharmaceutical companies. He replaces the interim chief executive, Cary Pfeffer. 11 July 2014
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze